|
H.I.V. Prevention Gel Hits Snag: Money
|
Donors have not yet committed enough money for studies needed to confirm a promising South African trial of a microbicide and to get the product to women.
 
|
|
Will Aging Chimps Get to Retire, or Face Medical Research?
|
A move of some of 186 chimpanzees to a research center in Texas has spurred outrage among animal rights advocates, primate experts and politicians.
|
|
Child’s Ordeal Shows Risks of Psychosis Drugs for Young
|
Powerful drugs are given to young children despite a lack of study on how they affect development.
|
|
Finding Suggests New Aim for Alzheimer’s Drugs
|
A discovery by Paul Greengard, an 84-year-old scientist and Nobel winner, has illuminated a new direction.
|
|
Study Sees Heart Risk in Meridia Diet Pill
|
A clinical trial found that the controversial drug increased the risks of heart attacks and strokes while doing little to slim their waists.
|
|
New Rivals to Warfarin as Blood Clot Preventer
|
A Bristol-Myers drug shows promise in treating a heart rhythm disorder, and others combat postsurgical clotting and deep vein thrombosis.
|
|
Majority of Caesareans Are Done Before Labor
|
A new study suggests several reasons for the nation’s rising Caesarean section rate.
|
|
Doctors Seek Way to Treat Muscle Loss
|
Why muscles wither is captivating more scientists and drug and food companies, let alone aging baby boomers.
|
|
Vital Signs: Longevity: For New York Men, a Life Expectancy Gap
|
Men die about six years younger, according to a new report from the New York City health department.
|
|
Vital Signs: Childhood: Athletes’ Concussions Have Doubled
|
The number doubled over a recent 10-year-period, a new study reports, even though participation in team sports decreased slightly.
|
